Immuneering is a clinical-stage oncology company dedicated to helping patients outlive their disease. Their lead product candidate, atebimetinib (IMM-1-104), is currently undergoing a Phase 2a trial for patients with advanced solid tumors, including pancreatic cancer. The company's R&D team operates from a ~38,000 square foot lab and office facility in San Diego, with additional offices in New York City and Cambridge, MA. Immuneering has grown to over 50 employees, all committed to applying their expertise, passion, and creativity to improve the lives of individuals with serious diseases. The team fosters a collaborative and relentless work environment, thinking across traditional boundaries to advance drug development.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Number of Employees
11-50 employees